Search

Your search keyword '"C. Lüers"' showing total 41 results

Search Constraints

Start Over You searched for: Author "C. Lüers" Remove constraint Author: "C. Lüers"
41 results on '"C. Lüers"'

Search Results

1. [Importance of interdisciplinary collaboration for optimal treatment of orbital tumors]

2. Sinus-piriformis-Fistel als seltene Ursache von Dyspnoe bei einem Neugeborenen

3. Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol absorption also regulate biliary secretion

4. Carbamazepine increases atherogenic lipoproteins: mechanism of action in male adults

6. [Systematic analysis of the readability of patient information on the websites of clinics for plastic surgery]

7. The low-dose monoethylglycinexylidide test: Assessment of liver function with fewer side effects

8. [Schwannoma in the epipharynx: a rare differential diagnosis]

10. [Reconstruction of the ossicular chain--current strategies]

11. [Unilateral tongue atrophy and articulation difficulties]

12. [Piriform sinus fistula resulting in acute dyspnea in a newborn]

13. [ANCA-negative subglottic laryngeal stenosis in childhood]

16. Carbamazepine increases APO B-containing lipoproteins and triglycerides but not HDL-cholesterol in a prospective study in healthy volunteers

17. 191-ASSOCIATIONS OF NT-PRO BNP WITH QUALITY OF LIFE AND ANXIETY IN MEN AND WOMEN WITH CHF RISK FACTORS

18. Apolipoprotein B-100 kinetics during treatment with carbamazepine - A prospective study in healthy males

21. Acute adverse events of Sars-CoV2 vaccines: Experiences from a health care worker vaccination campaign in two municipal hospitals in northwest Germany.

22. Morbidity and mortality in patients with cardiovascular risk factors and obstructive sleep apnoea: results from the DIAST-CHF cohort.

23. Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German Competence Network Heart Failure.

24. Arterial stiffness and elevated left ventricular filling pressure in patients at risk for the development or a previous diagnosis of HF-A subgroup analysis from the DIAST-CHF study.

25. Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.

26. Use of drug-eluting stents in acute myocardial infarction with persistent ST-segment elevation: results of the ALKK PCI-registry.

27. Asymptomatic Bland-White-Garland syndrome for 5 decades.

28. Impact of obstructive sleep apnoea on diastolic function.

29. Serum levels of interleukin-6 and interleukin-10 in relation to depression scores in patients with cardiovascular risk factors.

30. Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline.

31. The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction.

32. Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure.

33. [Importance of surfactant proteins B and D for the differential diagnosis of acute dyspnea].

34. Elevated serum levels of interleukin-10 and tumor necrosis factor α [corrected] are both associated with vital exhaustion in patients with cardiovascular risk factors.

35. Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure.

36. Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care.

37. Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension.

38. Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol absorption also regulate biliary secretion.

39. Influence of pyruvate on contractile performance and Ca(2+) cycling in isolated failing human myocardium.

40. Neuropeptide Y and peptide YY, but not pancreatic polypeptide, substance P, cholecystokinin and gastric inhibitory polypeptide, inhibit the glucagon- and noradrenaline-dependent increase in glucose output in rat liver.

41. The low-dose monoethylglycinexylidide test: assessment of liver function with fewer side effects.

Catalog

Books, media, physical & digital resources